Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2021-05-14 2021-03-19
Drug Identification Number 02416840 02416840
Brand name GABAPENTIN CAPSULES USP GABAPENTIN CAPSULES USP
Common or Proper name GABAPENTIN GABAPENTIN
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-03-19 2021-03-19
Actual start date
Estimated end date Unknown
Actual end date 2021-05-07
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments